Meeting Register Page

Meeting banner
Project 20/20: Drug Development Policy and its Discontents Part II
For anyone who is interested in learning more about navigating these issues from a legal research perspective, you won’t want to miss the second half of this program. The first session covered challenges facing drug development policy and the approval process. The second session will focus on the different ways the FDA incentivizes drug development. The material is drawn directly from a for-credit course taught at UCLA that provides an overview of drug development, the approval process (standard and fast track), along with other aspects of pharmaceutical innovation.

Lynn McClelland will be generously sharing her syllabus and will answer questions for anyone interested in learning more about this topic. She is a former pharma lab rat and currently is a Reference Librarian at UCLA where she has taught everything from Health Law & Policy Research to Nonprofit Law Drafting. She has collaborated with both legal and medical scholars and practitioners at the local, national, and international levels.

May 20, 2021 03:00 PM in Eastern Time (US and Canada)

Meeting is over, you can not register now. If you have any questions, please contact Meeting host: Project 20/20 Information.